TechFlow, June 18 — According to Globenewswire, Nasdaq-listed Prenetics announced the sale of its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for $71.78 million, bringing the company’s cash reserves to approximately $86 million and expected cash and short-term assets to $117 million. The company maintains a debt-free balance sheet with zero liabilities, positioning it to explore additional financial management strategies, including digital asset adoption and Bitcoin treasury initiatives.
Add to Favorites
Share to Social Media
